LOKELMATM Approved in the US for the Treatment of Adults with Hyperkalemia

LOKELMATM Approved in the US for the Treatment of Adults with Hyperkalemia


May 18, 2018-- AstraZeneca today announced that the US Food and Drug Administration has approved LOKELMA TM , formerly ZS-9, for the treatment of hyperkalemia in adults. 3 Hyperkalemia is a serious condition characterized by high levels of potassium in the blood .



from Biotech News